Lista de obras -

Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma

artículo científico publicado en 2007

Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and Perspectives

article

Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine?

artículo científico publicado en 2015

Beyond tissue biopsy: a diagnostic framework to address tumor heterogeneity in lung cancer

artículo científico publicado en 2020

CDK10 is not a target for aberrant DNA methylation in breast cancer.

artículo científico publicado en 2009

CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8. ⬇️

artículo científico publicado en 2012

Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program

artículo científico publicado en 2007

Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC.

artículo científico publicado en 2018

Cetuximab in non-small-cell lung cancer

artículo científico publicado en 2012

Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group

artículo científico publicado en 2005

Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop

scientific article published on October 2010

Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients

artículo científico publicado en 2015

Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITA.

scientific article published on 04 August 2013

Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy

artículo científico publicado en 2008

Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma

artículo científico publicado en 2002

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

artículo científico publicado en 2006

Decentral gene expression analysis for ER+/Her2− breast cancer: results of a proficiency testing program for the EndoPredict assay ⬇️

artículo científico publicado el 28 de febrero de 2012

Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer

artículo científico publicado en 2007

EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR

EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib

scientific article published on 01 April 2020

EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases

artículo científico publicado en 2009

EPN-07IMPACT OF CHROMOSOMAL ABERRATIONS AND MOLECULAR SUBTYPE ON TELOMERASE ACTIVATION IN PEDIATRIC EPENDYMOMA.

artículo científico publicado en 2016

ERCC1 and RRM1 in the international adjuvant lung trial by automated quantitative in situ analysis

artículo científico publicado en 2010

ERCC1 isoform expression and DNA repair in non-small-cell lung cancer

artículo científico publicado en 2013

Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy ⬇️

artículo científico publicado el 1 de septiembre de 2003

Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy

artículo científico publicado en 2003

Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.

artículo científico publicado en 2014

From crizotinib to lorlatinib: continuous improvement in precision treatment of ALK-positive non-small cell lung cancer

scientific article published on 08 September 2019

High p27Kip1 Expression Predicts Superior Relapse-Free and Overall Survival for Premenopausal Women With Early-Stage Breast Cancer Receiving Adjuvant Treatment With Tamoxifen Plus Goserelin ⬇️

artículo científico publicado el 1 de octubre de 2003

Highly refractory acute myeloid leukemia

artículo científico publicado en 2004

Hot Spot TERT Promoter Mutations Are Rare in Sporadic Pancreatic Neuroendocrine Neoplasms and Associated with Telomere Length and Epigenetic Expression Patterns

artículo científico publicado en 2020

IDO1+ Paneth cells promote immune escape of colorectal cancer

scientific article published on 22 May 2020

Integrating epidermal growth factor receptor-targeted therapies into platinum-based chemotherapy regimens for newly diagnosed non-small-cell lung cancer

artículo científico publicado en 2008

LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer

article

Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy

artículo científico publicado en 2009

MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma

artículo científico publicado en 2010

Monoclonal antibodies against EGFR in non-small cell lung cancer ⬇️

artículo científico publicado el 24 de noviembre de 2010

Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program

artículo científico publicado en 2007

MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancer

artículo científico publicado en 2010

PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs

artículo científico publicado en 2013

PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung Adenocarcinoma

scientific article published on 22 August 2018

PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition.

artículo científico publicado en 2015

Personalized treatment of advanced non-small-cell lung cancer in routine clinical practice

artículo científico publicado en 2016

Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy

artículo científico publicado en 2017

Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy

artículo científico publicado en 2013

Predictive markers in the adjuvant therapy of non-small cell lung cancer ⬇️

artículo científico publicado el 31 de agosto de 2011

Predictive value of molecular subtypes in premenopausal women with hormone receptor-positive early breast cancer: Results from the ABCSG Trial 5

artículo científico publicado en 2020

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer

artículo científico publicado en 2016

Prognostic Value of EndoPredict in Women with Hormone Receptor Positive, HER2-Negative Invasive Lobular Breast Cancer

scientific article published on 19 June 2020

Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis

artículo científico publicado en 2016

Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.

artículo científico publicado en 2014

Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells ⬇️

artículo científico publicado el 20 de noviembre de 2012

Targeted therapies in lung cancer

artículo científico publicado en 2009

Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain

artículo científico publicado en 2017

The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib

artículo científico publicado en 2020

The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer

artículo científico publicado en 2014

Lista de obras de

Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma

Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and Perspectives

Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine?

Beyond tissue biopsy: a diagnostic framework to address tumor heterogeneity in lung cancer

CDK10 is not a target for aberrant DNA methylation in breast cancer.

CYP2D6 metabolism and patient outcome in the Austrian Breast and Colorectal Cancer Study Group trial (ABCSG) 8. ⬇️

Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program

Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLC.

Cetuximab in non-small-cell lung cancer

Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group

Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop

Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients

Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITA.

Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy

Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

Decentral gene expression analysis for ER+/Her2− breast cancer: results of a proficiency testing program for the EndoPredict assay ⬇️

Downregulation of TSLC1 and DAL-1 expression occurs frequently in breast cancer

EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR

EGFR mutation tracking predicts survival in advanced EGFR-mutated non-small cell lung cancer patients treated with osimertinib

EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding locoregional lymph node metastases

EPN-07IMPACT OF CHROMOSOMAL ABERRATIONS AND MOLECULAR SUBTYPE ON TELOMERASE ACTIVATION IN PEDIATRIC EPENDYMOMA.

ERCC1 and RRM1 in the international adjuvant lung trial by automated quantitative in situ analysis

ERCC1 isoform expression and DNA repair in non-small-cell lung cancer

Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy ⬇️

Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy

Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.

From crizotinib to lorlatinib: continuous improvement in precision treatment of ALK-positive non-small cell lung cancer

High p27Kip1 Expression Predicts Superior Relapse-Free and Overall Survival for Premenopausal Women With Early-Stage Breast Cancer Receiving Adjuvant Treatment With Tamoxifen Plus Goserelin ⬇️

Highly refractory acute myeloid leukemia

Hot Spot TERT Promoter Mutations Are Rare in Sporadic Pancreatic Neuroendocrine Neoplasms and Associated with Telomere Length and Epigenetic Expression Patterns

IDO1+ Paneth cells promote immune escape of colorectal cancer

Integrating epidermal growth factor receptor-targeted therapies into platinum-based chemotherapy regimens for newly diagnosed non-small-cell lung cancer

LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer

Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy

MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma

Monoclonal antibodies against EGFR in non-small cell lung cancer ⬇️

Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program

MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancer

PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs

PD-1 and PD-L1 Protein Expression Predict Survival in Completely Resected Lung Adenocarcinoma

PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition.

Personalized treatment of advanced non-small-cell lung cancer in routine clinical practice

Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy

Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy

Predictive markers in the adjuvant therapy of non-small cell lung cancer ⬇️

Predictive value of molecular subtypes in premenopausal women with hormone receptor-positive early breast cancer: Results from the ABCSG Trial 5

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer

Prognostic Value of EndoPredict in Women with Hormone Receptor Positive, HER2-Negative Invasive Lobular Breast Cancer

Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis

Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.

Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells ⬇️

Targeted therapies in lung cancer

Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain

The Allele Frequency of EGFR Mutations Predicts Survival in Advanced EGFR T790M-Positive Non-small Cell Lung Cancer Patients Treated with Osimertinib

The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer